TheFly.com
Start Free Trial
<
Back to all Breaking News
IMAB, MOR
1/25/2021 16:01pm
8
Street Research Stories
2
Calendar Events
chevron_right
I-MAB, MorphoSys dose first patient in Phase 1 study of TJ210/MOR210 in cancer
Don't miss out!
We read the Wall Street research, SEC filings and press releases so you don't have to.
Sign up for our 14-day free trial to read this story.
Join Now
Learn More
Already have an account?
Sign In Here
Subscription Rates
dynamic_feed
Breaking News
search
Search
menu
Menu
